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Purpose of review
Obstructive sleep apnea is a diagnosis that non-primary care physicians can screen for when a patient
presents with certain risk factors. Recent literature provides strong data for associations between sleep
apnea and ocular disorders.
Recent findings
A potentially serious disorder, sleep apnea can lead to many systemic and ocular complications. Recent
findings provide data on the prevalence of sleep apnea with various disorders. Adequate treatment of
sleep apnea has also shown to reverse both systemic and eye related complications.
Summary

Early diagnosis and management of sleep apnea is critical for reducing the risk of devastating systemic
complications and preserving ocular and visual function. Further longitudinal data is needed to see the
effectivity of long term management of sleep apnea and its impact on reversing associated complications.
Keywords
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Introduction
Obstructive sleep apnea (OSA) is a potentially serious sleep disorder characterized by recurrent episodes
of breathing cessation during sleep secondary to an upper airway collapse (1). Complete apnea or partial
hypopnea episodes can last from 10-30 seconds and may occur up to hundreds of times nightly. It is
often accompanied with swings in heart rate, a decrease in oxygen saturation, and brief
electroencephalogram arousals.
Sleep apnea is a disorder not commonly diagnosed by the ophthalmologist, but an important one that has
many systemic and ocular complications. Furthermore, it is undertreated as patients defer treatment with
a continuous positive airway pressure (CPAP) mask, however, it can be reversed quickly with appropriate

treatment. Sleep apnea carries significant morbidity with a higher incidence of cardiovascular and
cerebral sequelae (2-3). It is associated with hypertension, diabetes, coronary artery disease, congestive
heart failure (4-5), atrial fibrillation (6); all of which may predispose one to a stroke. Additionally, OSA
has also recently been identified as an independent risk factor for stroke (7)••. There is also increasing
evidence that OSA coexists in epilepsy and that CPAP treatment improves seizure control, cognitive
performance and quality of life (8).

Epidemiology
Sleep apnea is an increasingly prevalent condition in both adults and children. Approximately 24% of
men and 9% of women have OSA, with and without excessive daytime sleepiness (9). In children, OSA
is a common but underdiagnosed condition, where the exact prevalence is less certain. One study
suggested approximately 6% of adolescents may have sleep-related disordered breathing (10). Many of
these children present with obesity and excessive daytime sleepiness and/or hyperactivity.

Pathophysiology
An anatomical deficiency of the upper airway is regarded as the most accepted theory regarding the
pathogenesis of OSA. Schwab et al. explained the increase soft tissue volume of soft palate, tongue,
parapharyngeal fat pads and lateral pharyngeal walls (11-13). Patients with OSA seem to also have a
smaller and an oval shaped pharyngeal airway with the long axis in the anterior-posterior orientation as
opposed to the short axis in the anterior-posterior orientation when compared to healthy subjects. Longer
airways are more easily collapsible than shorter airways and this recurrent pharyngeal collapse directly
obstructs the upper airway.

Predisposing factors
Excess weight and fat deposit around the upper airway may obstruct breathing. An increase in neck
circumference may also narrow the airway. A neck circumference greater than 17 inches (43 centimeters)
for males and 15 inches (38 centimeters) for females is associated with an increased risk. Chronic nasal
congestion can also narrow the upper airway. There is a relative increase in risk with hypertension and a
three-fold increase in patients with diabetes. Men are twice as likely as women to develop sleep apnea.
Among people under the age of 35, OSA is more common in blacks, Hispanics and Pacific Islanders.
Sleep apnea is three times more common in adults over the age of 65. Menopause appears to increase the
risk in females. Smokers have a three-fold increase than non-smokers and alcohol intake increases the
risk by relaxing the muscles in the throat.

Clinical Manifestations
The three cardinal symptoms of OSA include loud snoring, excessive daytime sleepiness and apnea
episodes. Observed episodes of breathing cessation during sleep and abrupt awakenings accompanied by
shortness of breath are common complaints. Other features include awakening with a dry mouth or sore
throat, morning headache, frequent urination at night and insomnia.

Diagnosis
The Epworth sleepiness scale is widely used as a screening test for OSA at a cutoff of 10 points (14).
Tests to detect sleep apnea include nocturnal polysomnography, oximetry and portable cardiorespiratory
testing. During nocturnal polysomnography testing, the physician can monitor the functions of the heart,

lungs and brain as well as rule out other conditions that can cause excessive daytime sleepiness. Pulse
oximetry readings will often be low during apnea with normalization upon awakening. A portable
cardiorepiratory testing device provides the patient the ability with a take-at-home test that measures
oximetry, along with airflow and breathing pattern measurements.

Management
Medical management
Treatment with CPAP quickly reverses symptoms of excessive daytime sleepiness and aids in
management of OSA. Continuous positive pressure, applied through a nasal mask, oronasal mask, or
nasal pillows, acts as a pneumatic splint to maintain upper airway patency during sleep. Adequate
treatment with CPAP has been demonstrated to show an over-recruitment of brain regions compared with
controls using functional MRI scanning (15) •. For patients who cannot tolerate CPAP therapy, bilevel
positive airway pressure (BiPAP) therapy is attempted next, which automatically adjusts the pressure
while one is sleeping. An oral appliance device is attempted if BiPAP is not tolerable to open the throat
by bringing the jaw forward. Additionally, modafinil 200-400mg/day has been shown to effectively
enhance alertness in patients with daytime somnolence (16).

Surgical management
Surgical management is reserved for patients in whom medical treatment cannot be tolerated or has failed.
Uvulopalatopharyngoplasty is the most common surgical procedure performed for adults with sleep
apnea. It involves the removal of the tonsils, the uvula, the distal margin of the soft palate and the
redundant pharyngeal tissue along with reshaping of the lateral pharyngeal walls. Genioglossus muscle
advancement with hyoid myotomy can also be used to expand the upper airway. Maxillomandibular
advancement osteotomy is usually reserved for patients in whom other surgical modalities fail. The

airway is expanded as the midface, palate, and mandible are moved forward. Finally, although a
tracheostomy may be the most effective, it is only reserved for patients with severe, life-threatening OSA
in whom other surgical treatments have all failed. Somnoplasty, or radiofrequency volumetric tissue
reduction of the soft palate, has recently generated much interest in treating OSA (17).

Associated Ocular Disorders
Floppy eyelid syndrome
Floppy eyelid syndrome (FES), first described in 1981 by Culbertson and Ostler (18), is characterized by
elastic upper eyelids that are easily everted with minimal lateral traction, associated with a papillary
conjunctivitis of the upper palpebral conjunctiva. A weak tarsal plate allows for the lid to fold upon itself
with ease. Obesity may be a confounding factor in the association of FES and OSA as many patients with
OSA suffer from obesity. Two recent studies provide insight into the role of obesity. Fowler and Dutton
conducted a case-based retrospective review of their patients along with a literature review for FES crossreferenced with factors including obesity and OSA. From their combined data, the overall prevalence of
sleep apnea in patients with lax eyelid was 16% compared with an estimated 9% to 24% in the general
population. Of patients with lax eyelid syndrome, patients identified with OSA had a significant greater
amount of individuals with obesity (76% vs. 20%) than individuals without OSA. Although sleep apnea
has been associated with FES, it did not seem to occur with greater frequency when compared to
individuals with obesity without FES in this study. Hence, the relationship between OSA and FES did
not seem to be a causal one, but an epiphenomenon related to common body habitus and gender (19) ••.
A recent case control study was conducted examining the association of FES and OSA while controlling
for BMI by Ezra et al. Their findings confirmed that OSA was significantly associated with FES, despite
correcting for weight. One possible mechanism, as explained by Ezra, may lie in changes in central
nervous system arousability in OSA. A decrease in cortical arousability may prevent these patients from

being disturbed by extreme mechanical stress to the upper lid during sleep, which would normally cause
an unaffected individual to wake from the mechanical stress (20) ••.

Glaucoma
Both normal tension (21-22) and primary open-angle glaucoma (23-24) have been associated with sleep
apnea. Theories of mechanism include: 1) impaired optic nerve head blood flow secondary to episodes of
apnea, 2) optic nerve vascular dysregulation secondary to arteriosclerosis and variations in arterial blood
pressure, and 3) episodes of hypoxia (25). As ocular blood flow has been suggested as a mechanism in
glaucoma, Karakucuk et al. investigated the prevalence of glaucoma and ocular blood flow with orbital
color Doppler ultrasonography in patients with OSA (26) •. The study included 31 patients with a
diagnosis of OSA and 25 health controls. Both groups had a similar distribution of other atherosclerotic
risk factors affecting ocular blood flow as there was no statistical difference between the two groups. The
prevalence of glaucoma was 12.9% amongst the OSA group, of which all patients belonged to the severe
OSA group [apnea-hypopnea index (AHI) >30]. There was no statistical significance between
ophthalmic artery resistivity index (OARI), central retinal artery resistivity index (CRARI) and
intraocular pressure (IOP) between patients and controls. There was a positive correlation between the
OARI and mean defect (MD), CRARI and MD, and CRARI and loss variance (LV) values, suggesting
that visual field defects may be due to defects in optic nerve perfusion. Also, a significant positive
correlation was noted between IOP and the AHI, suggesting that increased IOP may reflect the severity of
OSA. Kargi et al. used a scanning laser polarimeter to examine the retinal nerve fiber layer (RNFL) in 34
patients with OSA. The thickness was reduced in patients with OSA when compared to controls, as well,
a correlation was noted between the decrease in thickness with the severity of sleep apnea (27).

Non-Arteritic Ischemic Optic Neuropathy

Mojon et al. has hypothesized several theories in a correlation between OSA and NAION. An ischemic
event may be secondary to impaired optic nerve head blood flow autoregulation from apnea. Optic nerve
vascular dysregulation may also be a result of variations in arterial blood pressure seen in OSA, which
may be due to an imbalance between nitric oxide and endothelin. Additionally, direct damage by periods
of hypoxia likely plays a role (25, 28). Older studies had noted visual field defects consistent with an
optic neuropathy in patients with OSA, however, data had not demonstrated a direct causal relationship
between OSA and visual field defects (28). Mojon et al., in a case series, noted a high prevalence of OSA
in patients with NAION, where 71% patients with NAION had OSA versus 18% of control patients with
OSA in a study of 34 patients. He explained this may be why 75% of all patients with NAION
discovered visual loss upon awakening in the morning (29). Palombi et al. had noted an even higher
prevalence in his study where 89% of patients with NAION had sleep apnea (30). Patient with NAION
who may have symptoms of OSA should undergo polysomnography. It is yet to be studied, however, if
treatment of OSA reduces the risk of occurrence or recurrence of NAION (31).

Papilledema
Bucci and Krohel first reported a case of papilledema in a patient with OSA in 1988 (32), who had
surgical treatment correcting his OSA which resolved his papilledema. Since, then, numerous cases have
been reported of patients found to have papilledema and idiopathic intracranial hypertension. Many of
these patients, however, have had normal opening pressures on lumbar puncture. Correction of their OSA
with CPAP treatment had resolved the papilledema (33-36). The normal intracranial pressure (ICP) was
best explained by Sugita et al. (37) who monitored continuous ICP in patients with OSA. Although all
patients had normal ICP during the daytime, large increases in nocturnal ICP occurred which correlated
with apneic events. Additionally noted was the degree of increase in ICP which also correlated with the
duration of the apnea.

Until recently, the prevalence of OSA in patients with papilledema was not looked at. Peter et al.
questioned 35 patients with OSA regarding visual symptoms suggestive of papilledema, where 40%
reported some symptoms suggestive of papilledema. Upon funduscopic examination, none of the patients
had signs of papilledema. Although papilledema has been associated with patients with OSA in previous
reports, it is not a frequent finding in patients with OSA (38) •.
Bruce et al. (39) •• recently conducted a retrospective chart review, looking at 721 patients, including 66
men and 655 women, with sleep apnea. This is the largest study to date of IIH in men. Men were more
likely to have OSA (24% vs. 4%) than women. Also, men were almost twice as likely to develop visual
changes (35% vs. 20%) and had fewer symptoms of headache (55% vs. 75%) as compared to women.
The debate will continue if whether OSA is causal or a comorbidity amongst patients with IIH. If causal,
we still do not have a plausible mechanism (40). Additional questions, as if the visual outcome in
patients with increased ICP is affected by the presence of OSA needs to be looked at in future studies.
Screening however, is recommended in all patients with OSA who may have visual symptoms (31).

Central Serous Chorioretinopathy
Patients with sleep apnea have increased levels of circulating epinephrine and norepinephrine. With
elevated levels of catecholamines, OSA has been hypothesized to be a direct risk factor for central serous
chorioretinopathy (CSCR). Leveque et al. examined 29 patients with CSCR in a retrospective casecontrolled study to assess the risk of sleep apnea. With the use of the Berlin Questionnaire for OSA, their
study revealed 58.6% of patients with CSCR to be at an increased risk for OSA compared to the control
group of 31% (41) •. Kloos et al. then reported that 22% of patients in his series of 36 patients, with acute
or chronic CSCR, suffered from OSA compared to the general population (2-4%) (42) •. More recently,
Jain et al. reported the first case of bilateral CSCR in a 45-year-old male found to have OSA that resolved
with treatment of his OSA. Within one week of starting CPAP treatment, the patient noted an

improvement of his vision and his visual acuity improved from 20/30 in his right eye (OD) and 20/40 in
his left eye (OS) to 20/20 OD and 20/25 OS. Additionally, his serous detachments had resolved on
examination and on OCT (43) ••. The most important factor in managing CSCR is recognizing and
removing any inciting risk factors, as its natural history is typically favorable with resolution within six
months.

Retinal Vein Occlusion
Leroux les Jardins et al. recently investigated the association between retinal vein occlusions and OSA.
They are the first to report three patients who presented with retinal vein occlusions and found to have
OSA. They hypothesized, that retinal vein occlusions may be associated with OSA as they may be
secondary to a slow-down of blood flow circulation secondary to hypoxemia and elevated nocturnal
intracranial pressure. Strictly acting on the retinal microcirculation, OSA may directly have a causal
effect on retinal vein occlusions (44).

Conclusion
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